Z-0127-2025 Class II Ongoing

Recalled by CHANGE HEALTHCARE CANADA COMPANY — Richmond

FDA device recall Z-0127-2025 was initiated by CHANGE HEALTHCARE CANADA COMPANY on Aug 21, 2024 and is designated Class II. Reason for recall: A potential issue has been identified in Change Healthcare Cardiology Hemo where incorrect data entry can lead to inaccurate hemodynamic calculations, potentially resulting in misdiagnosis and… The recall status is ongoing. Affected quantity: 3 systems.

Recall details

Product Type
Devices
Report Date
Oct 23, 2024
Initiation Date
Aug 21, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3 systems

Product description

Horizon Cardiology Hemo. Version 12.2.

Reason for recall

A potential issue has been identified in Change Healthcare Cardiology Hemo where incorrect data entry can lead to inaccurate hemodynamic calculations, potentially resulting in misdiagnosis and inappropriate treatment. This issue occurs when the unit of measurement (UOM) for hemoglobin is configured in a way that differs from the users understanding.

Distribution pattern

Worldwide distribution - US Nationwide and the countries of Australia, Canada, Germany, Ireland, Israel, United Kingdom.

Code information

No UDI. Version 12.2

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0127-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0127-2025. Report a data issue: hello@regdatalab.com.